Target intelligence / Profile preview

Memory T-lymphocyte (Tm cell) (Tm cell)

Target
Tm cell
Molecular classification
Other
01

Overview

Memory T-lymphocytes are a specialized subset of antigen-experienced T cells that persist long-term after an initial immune challenge (StatPearls, 2023). They are characterized by their ability to mount a faster and more potent immune response upon re-exposure to a specific pathogen or antigen compared to naive T cells (Nature Reviews Immunology, 2013). These cells are broadly classified into central memory (Tcm), effector memory (Tem), and tissue-resident memory (Trm) subsets based on their expression of markers like CCR7 and CD62L and their localization (PubMed, PMC4406145). While essential for long-term immunity against infections and cancer, dysregulated memory T cells can drive chronic inflammatory conditions and autoimmune diseases (NIH, 2018). Pharmacological intervention typically targets specific receptors on these cells, such as CD52 or CD25, to either deplete them or modulate their activation and proliferation (Journal of Clinical Investigation, 2015).

Other names
Memory T cellAntigen-experienced T cellCD45RO+ T cell
02

Mechanism of action

Therapeutic agents modulate memory T-lymphocytes by targeting surface proteins (e.g., CD52, CD25) to induce cell depletion, or by interfering with intracellular signaling pathways (e.g., calcineurin inhibition, mTOR inhibition) to suppress activation and proliferation (Journal of Clinical Investigation, 2015). Additionally, some drugs sequester these cells in lymphoid tissues by targeting trafficking receptors like S1P (Nature Reviews Drug Discovery, 2013).

03

Biological functions

Immune responseImmunological memoryCytokine productionCell proliferationCytotoxicity
04

Disease associations

InfectionCancerInflammationAutoimmune diseaseGraft-versus-host disease
05

Safety considerations

Increased risk of opportunistic infectionsReduced vaccine efficacyPotential for autoimmune flaresGeneral immunosuppressionRisk of Progressive Multifocal Leukoencephalopathy (PML)
06

Interacting drugs

Alemtuzumab

8 more in the full profile.

07

Biomarkers

CD45ROCCR7CD62LCD127CD95CD27CD28

Beyond the preview

Go deeper on Memory T-lymphocyte (Tm cell) (Tm cell).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Memory T-lymphocyte (Tm cell) (Tm cell).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call